Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: BSGrinder who wrote (77308)	3/9/2000 10:48:00 AM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

Kit, Any valuation model depends upon inputs and I had to input a faster rate of acceptance after the Mayo Clinic report. I haven't factored in the new indications from Left Ventricle heart failure yet. So, with acceptance and use likely to move much faster than I had previously calculated, the value moves up. Vaso is now fairly priced at $25, according to my model. The trick with these models is not to fudge the inputs to conform to your bias. I have tried not to do that, though the new left ventricle info is pretty dramatic.